🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label, multi-center clinical study to evaluate t...
Status
Unknown
Location
Nanfang Hospital, Southern Medical University
Start Date
2024-04
Trial ID
NCT06202716
Treatments Being Tested
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Status
Not Yet Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-11-01
Trial ID
NCT06089382
Treatments Being Tested
This research is being done to study the safety and feasibility of implanti...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-12-01
Trial ID
NCT05700461
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of c...
Status
Recruiting
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH)
Start Date
2024-03-11
Trial ID
NCT06363006
Treatments Being Tested
QL1706 Combined with Lenvatinib and GEMOX as First - Line Treatment for Unr...
Status
Active Not Recruiting
Location
the Third Affiliated Hospital of Naval Medical University
Start Date
2025-06-14
Trial ID
NCT06892925
Treatments Being Tested
This study is designed as a prospective, randomized, open-label, phase II c...
Status
Recruiting
Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH), Beijing, 100730
Start Date
2025-06-01
Trial ID
NCT07679399
Treatments Being Tested
This multicenter retrospective study evaluated consecutive patients with la...
Status
Completed
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2019-07-01
Trial ID
NCT06265883
Treatments Being Tested
The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Start Date
2026-05-06
Trial ID
NCT07571551
Treatments Being Tested
This research study is studying Lenvatinib in combination with Pembrolizuma...
Status
Recruiting
Location
Yale University
Start Date
2025-07-18
Trial ID
NCT04645602
Treatments Being Tested